CurrentEndo
Get Weekly

Topic · page 9 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 321–360 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Mental Health Disorders in Type 2 Diabetes: Active Comparator, New User Cohort Study

    Cohort study

  2. Diabetes Obes Metab

    Modelling the Clinical and Complication‐Related Economic Burden of Therapeutic Inertia in People With Type 2 Diabetes in China

    Research article

  3. Ann Intern Med

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial

    Randomized controlled trial

  4. Cardiovasc Diabetol

    Deep learning analysis of ECGs detects Cardiovascular–Kidney–Metabolic syndrome burden in people with diabetes: a report from the Silesia Diabetes-Heart Project

    Diagnostic or prognostic study

  5. BMJ Open Diabetes Res Care

    Hyperosmolar hyperglycaemic state: a systematic review and meta-analysis

    Meta-analysis

  6. Diabetes Obes Metab

    Shifts in Incident Glucose Lowering Drug Initiation in Type 2 Diabetes From 2014 to 2024: A Population‐Based Study

    Cohort study

  7. Cardiovasc Diabetol

    Integrating lipometabolic and adiposity indices to enhance risk stratification for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: clinical utility and interplay between triglyceride-glucose body mass index and low-density lipoprotein cholesterol

    Diagnostic or prognostic study

  8. Diabet Med

    Perioperative glycaemic profiles in Aboriginal and Torres Strait Islander people with diabetes mellitus

    Cohort study

  9. Diabetes Obes Metab

    Real‐World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan

    Cohort study

  10. Endocr Pract

    Effectiveness of GLP-1 Receptor Agonists and SGLT-2 Inhibitors Combination Therapy in Type 2 Diabetes: A Real-World Experience

    Cohort study

  11. Diabetes Care

    A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes

    Diagnostic or prognostic study

  12. Diabet Med

    Under‐ and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomes

    Cohort study

  13. Diabetes Obes Metab

    Prevalence of Obesity and Related Conditions and GLP ‐1 Use in Medicare Fee‐for‐Service Beneficiaries

    Cohort study

  14. Diabetes Care

    Proteomic Signatures of 3-Year Progression From Impaired Fasting Glucose to Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

    Cohort study

  15. Diabetes Care

    Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant

    Randomized controlled trial

  16. Diabetes Metab

    Glucagon-like peptide-1 receptor agonists and risk of pancreaticobiliary cancers in patients with type 2 diabetes: a nationwide cohort study

    Cohort study

  17. Diabetes Res Clin Pract

    Glucagon and beta-cell function changes before and after dietary weight loss-induced metabolic improvements in type 2 diabetes

    Cohort study

  18. Diabetes Res Clin Pract

    Effects of different exercise modalities and doses on glycated hemoglobin in patients with type 2 diabetes mellitus and overweight or obesity: a systematic review and Bayesian multilevel network meta-analysis

    Meta-analysis

  19. J Clin Endocrinol Metab

    Reversible mitochondrial iron toxicity in Wolfram syndrome type 2 monogenic diabetes

    Cohort study

  20. Diabetes Res Clin Pract

    Reproducibility of the diagnosis of diabetes by the 1-hour oral glucose tolerance test is substantial

    Diagnostic or prognostic study

  21. Cardiovasc Diabetol

    Association between insulin resistance surrogate markers and cardiovascular disease risk in individuals with subclinical metabolic disorders: a prospective cohort study based on baseline levels, cumulative exposure, and longitudinal trajectories

    Cohort study

  22. Diabetes Obes Metab

    Efficacy and Safety of GLP ‐1 Receptor Agonists on Combined Cardiovascular and Renal Outcomes in Patients With Chronic Kidney Disease: A Systematic Review and Meta‐Analysis

    Meta-analysis

  23. Ann Intern Med

    Expanding Technology-Enabled, Nurse-Delivered Chronic Disease Care : A Pragmatic, Randomized, Effectiveness-Implementation Trial

    Randomized controlled trial

  24. Diabetes Obes Metab

    A Four‐Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin‐Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot Study

    Secondary analysis

  25. Cardiovasc Diabetol

    An interpretable machine learning model for predicting postoperative hypotension in type 2 diabetes mellitus undergoing non‑cardiac surgery

    Diagnostic or prognostic study

  26. Diabetes Obes Metab

    Dual Glucagon and GLP ‐1 Receptor Agonist Survodutide Improves Biomarkers of Beta‐Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity

    Secondary analysis

  27. Diabetes Obes Metab

    Large‐Scale Proteomics Uncovers Pre‐Disease Inflammation–Lipid Subtypes to Refine Risk Stratification and Prediction of Type 2 Diabetes

    Cohort study

  28. Cardiovasc Diabetol

    Optimizing early triage for subclinical cardiovascular-kidney-metabolic syndrome: longitudinal associations, incremental value, and clinical utility of nine insulin resistance surrogates

    Cohort study

  29. Diabetes Obes Metab

    Association of Sodium‐Glucose Cotransporter‐2 Inhibitors With Incident Gout Risk: A Population‐Based Comparative Cohort Study With Genetic Evidence From Mendelian Randomisation

    Cohort study

  30. Diabet Med

    Wolfram syndrome and diabetes mellitus in Aotearoa, New Zealand: Phenotype and response to GLP ‐1 receptor agonist therapy

    Cohort study

  31. Diabetes Res Clin Pract

    Exercise as targeted therapy in type 2 diabetes: a phenotype-informed clinical prioritisation framework for adapted physical activity

    Guideline or statement

  32. Diabetes Res Clin Pract

    A study on the efficacy and safety of fosfomycin for the treatment of Multidrug-Resistant Enterobacterales urinary tract infection in North Indian type 2 diabetes mellitus patients

    Cohort study

  33. Cardiovasc Diabetol

    Proteomics of multimorbidity progression across cardiometabolic diseases and cancer in a multinational cohort

    Cohort study

  34. Cardiovasc Diabetol

    Predictive significance of triglyceride-glucose index in forecasting adverse cardiovascular events among Type 2 diabetes mellitus patients with co-existing metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies

    Cohort study

  35. Diabetes Care

    To Cluster or Not to Cluster? A Comparison of Approaches to Targeting Type 2 Diabetes Glucose-Lowering Therapy in the TriMaster Crossover Trial

    Secondary analysis

  36. Diabetes Res Clin Pract

    Screening and staging type 2 diabetes risk with a 1 h oral glucose tolerance test and the Finnish diabetes risk score

    Cohort study

  37. Cardiovasc Diabetol

    Exercise modalities and dosages on glycated haemoglobin and exerkines in type 2 diabetes: a systematic review with pairwise, network, and dose-response meta-analyses

    Meta-analysis

  38. Diabet Med

    A 4‐week community‐implemented diabetes prevention program is associated with improved metabolic outcomes at 12 months after participation

    Research article

  39. Diabetes Obes Metab

    Aerobic Exercise Training Increases Circulating sRAGE in Adults With Type 2 Diabetes: Associations With Sheddase Regulation

    Randomized controlled trial

  40. Diabetes Obes Metab

    Effect of a Novel GLP ‐1 Analogue Ecnoglutide on the Pharmacokinetics of Rosuvastatin and Digoxin in Healthy Participants

    Research article

All 4,758 Briefs in ExploreShowing Briefs 321–360 of 4,758, newest first